PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,601,991 | -16.9% | 39,390 | -1.0% | 0.14% | -32.9% |
Q1 2023 | $1,926,943 | +17.7% | 39,780 | -7.3% | 0.21% | +15.1% |
Q4 2022 | $1,637,340 | -10.6% | 42,896 | +17.6% | 0.18% | +2.8% |
Q3 2022 | $1,831,000 | +9.2% | 36,471 | -4.7% | 0.18% | +13.9% |
Q2 2022 | $1,676,000 | +36.5% | 38,277 | +16.3% | 0.16% | +75.6% |
Q1 2022 | $1,228,000 | -78.5% | 32,926 | -77.0% | 0.09% | -75.3% |
Q4 2021 | $5,709,000 | +1.8% | 143,344 | -4.9% | 0.36% | +0.3% |
Q3 2021 | $5,609,000 | +3.4% | 150,751 | +17.5% | 0.36% | +1.7% |
Q2 2021 | $5,425,000 | -15.3% | 128,353 | -5.1% | 0.36% | -22.3% |
Q1 2021 | $6,404,000 | -8.4% | 135,253 | +18.1% | 0.46% | -11.7% |
Q4 2020 | $6,991,000 | +52.2% | 114,553 | +22.1% | 0.52% | +27.9% |
Q3 2020 | $4,592,000 | +37.5% | 93,853 | +42.6% | 0.41% | +22.2% |
Q2 2020 | $3,339,000 | +24.5% | 65,815 | +9.5% | 0.33% | -4.0% |
Q1 2020 | $2,682,000 | +10.3% | 60,117 | +18.7% | 0.35% | +33.3% |
Q4 2019 | $2,432,000 | +220.4% | 50,635 | +125.6% | 0.26% | +196.6% |
Q3 2019 | $759,000 | – | 22,445 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |